Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Julia Thornton Snider, PhD
Advertisement
Articles by Julia Thornton Snider, PhD
Advertisement
Latest Updated Articles
- The Potential Impact of CAR T-Cell Treatment Delays on Society
Published: August 13th 2019 | Updated:
Advertisement
Advertisement
